Regencell Corp - RGC Company Short-Term Debt

Graphic logo of Regencell Bioscience Holdings Limited (RGC)

Regencell Bioscience aims to capture the autism and ADHD therapy niche by implementing Chinese medicine methods. However, trade wars between the US and China are hindering the exchange of biodata and joint research. GURU.Markets analytics includes this chart of short-term debt book value with a metric value of 0.00. There is a high probability that funds will be exhausted before the product reaches the market.

RGC: regencellbioscience.com Short-Term Debt 07/04/2022 - 10/28/2026

Regencell Corp - analytical breakdowns and key metrics (RGC)

- price and consensus price forecast:
Price Chart Regencell Bioscience Holdings Limited|RGC - Average Forecast Price
- market capitalization data:
Market Value Regencell Bioscience Holdings Limited|RGC - Value Adjusted for Debt and Cash
- book capitalization data:
Book Value per Share Regencell Bioscience|RGC - Total Stockholders' Equity|Market Capitalization to Book Value Ratio regencellbioscience.com|RGC - Company Balance Sheet Assets
- debt and liquidity data:
Total Debt to Capital Regencell Bioscience|RGC - Long-Term Liabilities to Capital|Short-Term Debt to Equity Regencell Bioscience|RGC - Company Aggregate Debt|Debts to Book Capitalization Regencell Bioscience Holdings Limited|RGC - Company Long-Term Liabilities|Company Short-Term Debts Regencell Bioscience
Analysis of all company metrics:Regencell Bioscience Holdings Limited - RGC
Finished products of Regencell Bioscience

Investors are assessing the financial stability of Regencell Bioscience (RGC) through its current liabilities, which measure the current debt load and the business's ability to service its loans. By analyzing the volume of short-term liabilities, one can determine how effectively the company is financing the early stages of developing plant-based treatments for ADHD while avoiding critical liquidity shortages within a niche market.

Competitors of Regencell Bioscience (RGC)

BIIB (Biogen) - Company Short-Term Debt|NBIX: Short-Term Debt|Company Short-Term Debt Axsome Therapeutics Inc AXSM|ACADIA Corp (ACAD) - Company Short-Term Loans and Borrowings|Company Short-Term Debts XENE (Xenon Pharmaceuticals)|Short-Term Debt vikingtherapeutics.com|SUPN: Company Short-Term Debts|Short-Term Indebtedness Catalyst Pharma (CPRX)|DNLI: Company Short-Term Debts|Harmony Corp - Short-Term Debt|Biohaven Ltd. (BHVN) - Company Short-Term Debt|AMLX - Company Short-Term Indebtedness|TRVI (Trevi Therapeutics, Inc.) - Company Short-Term Debts|Praxis Precision Medicines Inc (PRAX) - Company Current Liabilities|Company Short-Term Debts AVXL (Anavex Corp)|Short-Term Debt CBLL|Company Short-Term Debt Prothena (PRTA)|Company Short-Term Debt ALEC (alector.com)|Company Short-Term Debt Annexon ANNX|OMER - Company Short-Term Debt|Company Current Liabilities Neurogene Corp (NGNE)|ACIU - Company Short-Term Loans and Borrowings|Voyager Therapeutics (VYGR) - Company Short-Term Debts|neumoratx.com (NMRA) - Company Short-Term Debt|SCLX: Company Short-Term Debts|Short-Term Debt Volume TVGN|Alpha Cognition - Company Short-Term Debt|Short-Term Debt CGTX (cogrx.com)|Company Short-Term Debt IKT|Short-Term Debt Volume cassavasciences.com SAVA|ASRT: Company Short-Term Debts|COYA - Company Current Liabilities|vistagen.com - Company Short-Term Debts|Ovid Therapeutics (OVID) - Short-Term Debt Volume|Company Short-Term Debts ABOS (Acumen Pharmaceuticals)|Short-Term Debt CRVO|Company Short-Term Debt Alterity Therapeutics ATHE|Company Short-Term Indebtedness clene.com (CLNN)|PepGen - Company Short-Term Debts|Company Current Liabilities jupiterneurosciences.com JUNS|RLMD (Relmada Therapeutics) - Company Short-Term Debts|ANVS: Short-Term Debt|Company Short-Term Debt gracetx.com GRCE|Firefly Neuroscience, Inc. (AIFF) - Company Short-Term Loans and Borrowings|ANEW Medical - Company Short-Term Debts|Short-Term Indebtedness NeuroSense Therapeutics, Ltd.|Company Short-Term Debts RVPH (Reviva Pharmaceuticals)|Company Current Liabilities MTVA (metaviatx.com)|NRXS - Company Short-Term Debt|Company Short-Term Indebtedness Helius Medical Technologies, Inc. HSDT|PASG (Passage Bio Corp) - Company Short-Term Debts|Neuphoria Therapeutics Inc. (NEUP) - Short-Term Debt|NERV: Company Current Liabilities|ATHA (athira.com) - Company Short-Term Debts|ADXN - Company Short-Term Debt|Company Short-Term Loans and Borrowings ALZN|Cyclerion Therapeutics - Company Short-Term Debt|Short-Term Debt PTIX (protagenic.com)|Company Short-Term Debt Pasithea Therapeutics Corp.|Company Short-Term Loans and Borrowings Cortigent Inc CRGT|ATXI (Avenue Therapeutics, Inc.) - Company Short-Term Debts|BCLI - Short-Term Debt|Company Short-Term Debts CARA (Cara Therapeutics, Inc)|Chromocell (CHRO) - Short-Term Indebtedness|Company Short-Term Debts ELYM (Eliem Therapeutics, Inc.)|Short-Term Debt ITCI|Company Short-Term Debt Longboard Pharmaceuticals, Inc. LBPH|Company Short-Term Indebtedness Marinus Pharmaceuticals Inc (MRNS)|NKGen - Company Short-Term Debts|Company Current Liabilities NeuroBo Pharma NRBO|SAGE (Sage Therapeutics, Inc.) - Company Short-Term Debts|SNPX: Short-Term Debt|Trevena (TRVN) - Company Short-Term Debt|VIGL (Vigil Neuroscience, Inc.) - Company Short-Term Debt|Company Short-Term Debt Anew Medical, Inc.|Company Short-Term Debt Cerevel Corp (CERE)